Related Experiment Videos

Induction of specific-locus and dominant lethal mutations in male mice by busulfan

U H Ehling1, A Neuhäuser-Klaus

  • 1GSF-Institut für Säugetiergenetik, Neuherberg, F.R.G.

Mutation Research
|August 1, 1991
PubMed

Insights

Busulfan, a chemotherapy drug, causes genetic mutations in male mice. It induces dominant lethal and specific-locus mutations in sperm cells (spermatozoa and spermatids) but not in spermatogonia.

Area of Science:

  • Toxicology
  • Genetics
  • Reproductive Biology

Background:

  • Busulfan is a chemotherapeutic agent used in cancer treatment.
  • Understanding its genotoxic effects is crucial for assessing risks in patients.

Purpose of the Study:

  • To investigate the mutagenic potential of busulfan in male mice.
  • To determine the specific germ cell stages affected by busulfan-induced mutations.

Main Methods:

  • Male mice were administered varying doses of busulfan (5 mg/kg and 20 mg/kg).
  • Dominant lethal mutations were assessed by examining offspring viability.
  • Specific-locus mutations were evaluated by scoring 83,196 offspring.

Main Results:

  • Busulfan induced dominant lethal mutations in spermatozoa at 5 mg/kg.
  • At 20 mg/kg, busulfan induced dominant lethal mutations in spermatozoa and spermatids.
  • Specific-locus mutations were observed in spermatozoa and spermatids, but not in spermatogonia.

Conclusions:

  • Busulfan is a mutagen in male mouse germ cells.
  • The sensitivity of germ cell stages to busulfan-induced mutations is similar for dominant lethal and specific-locus mutations but not identical.

Related Concept Videos